Fennec Pharmaceuticals Correlations
FENC Stock | USD 5.66 0.34 6.39% |
The current 90-days correlation between Fennec Pharmaceuticals and Scpharmaceuticals is 0.1 (i.e., Average diversification). The correlation of Fennec Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Fennec Pharmaceuticals Correlation With Market
Weak diversification
The correlation between Fennec Pharmaceuticals and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Fennec |
Moving together with Fennec Stock
0.8 | VALN | Valneva SE ADR | PairCorr |
0.62 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.75 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.69 | IPSC | Century Therapeutics | PairCorr |
0.63 | MTEM | Molecular Templates | PairCorr |
0.8 | NKTX | Nkarta Inc | PairCorr |
0.64 | TPST | Tempest Therapeutics | PairCorr |
0.75 | AGL | agilon health Buyout Trend | PairCorr |
0.74 | BACK | IMAC Holdings | PairCorr |
0.75 | CYRX | Cryoport | PairCorr |
0.67 | SHG | Shinhan Financial | PairCorr |
0.79 | EC | Ecopetrol SA ADR | PairCorr |
0.63 | TLK | Telkom Indonesia Tbk | PairCorr |
Moving against Fennec Stock
0.74 | KZR | Kezar Life Sciences | PairCorr |
0.6 | MLYS | Mineralys Therapeutics, | PairCorr |
0.78 | HD | Home Depot | PairCorr |
0.76 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.75 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.74 | T | ATT Inc Sell-off Trend | PairCorr |
0.72 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
0.65 | HPQ | HP Inc | PairCorr |
0.63 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.59 | BAC | Bank of America Aggressive Push | PairCorr |
0.5 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.48 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
0.46 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
0.46 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
0.45 | VFS | VinFast Auto Earnings Call Today | PairCorr |
0.37 | KB | KB Financial Group | PairCorr |
Related Correlations Analysis
-0.01 | 0.87 | -0.52 | 0.83 | -0.66 | ELYM | ||
-0.01 | -0.17 | 0.1 | 0.11 | 0.01 | HCWB | ||
0.87 | -0.17 | -0.52 | 0.72 | -0.57 | SCPH | ||
-0.52 | 0.1 | -0.52 | -0.42 | 0.49 | MIST | ||
0.83 | 0.11 | 0.72 | -0.42 | -0.6 | MCRB | ||
-0.66 | 0.01 | -0.57 | 0.49 | -0.6 | LUMO | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Fennec Stock performing well and Fennec Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fennec Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ELYM | 3.92 | (0.95) | 0.00 | (5.36) | 0.00 | 6.21 | 34.87 | |||
HCWB | 13.22 | 4.45 | 0.42 | (1.48) | 7.39 | 22.00 | 352.85 | |||
SCPH | 2.68 | (0.82) | 0.00 | (0.32) | 0.00 | 4.30 | 20.70 | |||
MIST | 1.92 | 0.21 | 0.13 | 0.25 | 1.60 | 7.19 | 18.66 | |||
MCRB | 4.68 | 0.01 | (0.02) | 0.25 | 5.68 | 10.00 | 28.84 | |||
LUMO | 2.77 | 0.61 | 0.15 | (3.14) | 2.60 | 6.35 | 26.13 |
Fennec Pharmaceuticals Corporate Management
Mark Meier | VP Commercial | Profile | |
Christiana MBA | Chief Officer | Profile | |
Mark Gowland | Controller | Profile | |
Terry Evans | Chief Officer | Profile | |
Robert Andrade | Chief Officer | Profile | |
Dr MS | Chief Officer | Profile |